Literature DB >> 8888257

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

B Dubray1, V Mosseri, F Brunin, C Jaulerry, P Poncet, J Rodriguez, J Brugère, D Point, P Giraud, J M Cosset.   

Abstract

PURPOSE: To evaluate the prognostic value of anemia in squamous cell carcinomas in the head and neck treated with curative radiation therapy alone.
MATERIALS AND METHODS: In a prospective study, the hemoglobin level was measured prior to radiation therapy in 217 patients (188 [87%] men and 29 [13%] women) with cancer of the oral cavity (n = 61 [28%]), oropharynx (n = 53 [24%]), hypopharynx (n = 21 [10%]), and larynx (n = 82 [38%]). Anemia, defined as hemoglobin level below 13.5 g/dL in men and below 12.0 g/dL in women, was diagnosed in 58 (31%) of the men and five (17%) of the women. Median follow-up was 29 months (range, 2-63 months).
RESULTS: The 2-year actuarial probability of local-regional control was 69% (95% confidence interval, 63%, 76%). Multivariate analysis showed the relative risk of failure of local-regional control to increase for stage T3 and T4 tumors (1.8 [95% confidence interval, 1.1, 3.1]), stage N3 nodes (3.6 [95% confidence interval, 1.8, 7.1]), weight loss (2.2 [95% confidence interval, 1.3, 4.0]), and anemia (1.6 [95% confidence interval, 1.0-2.7]). The relative risk of death increased for stage T3 and T4 tumors (2.5 [95% confidence interval, 1.4, 4.3]), N3 nodes (4.0 [95% confidence interval, 1.0, 7.9]), oral cavity tumors (2.0 [95% confidence interval, 1.2, 3.2]), male sex (4.1 [95% confidence interval, 1.3, 13.1]), weight loss (2.2 [95% confidence interval, 1.3, 3.7]), and anemia (1.7 [95% confidence interval, 1.03, 2.7]).
CONCLUSION: Moderate anemia appeared to be an independent prognostic factor in squamous cell carcinoma of the head and neck treated with radiation therapy alone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888257     DOI: 10.1148/radiology.201.2.8888257

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  28 in total

Review 1.  Impact of anemia in patients with head and neck cancer treated with radiation therapy.

Authors:  Kenneth Hu; Louis B Harrison
Journal:  Curr Treat Options Oncol       Date:  2005-01

Review 2.  Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

3.  The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients.

Authors:  Xianren Ye; Jingfu Liu; Yujuan Chen; Na Wang; Rong Lu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.

Authors:  M Grimm; M Lazariotou
Journal:  Med Oncol       Date:  2011-08-19       Impact factor: 3.064

6.  Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.

Authors:  Yiting Cao; Justin D Lathia; Christine E Eyler; Qiulian Wu; Zhizhong Li; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Genes Cancer       Date:  2010-01-01

7.  Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.

Authors:  Hee Chul Park; Nora A Janjan; Tito R Mendoza; Edward H Lin; Saroj Vadhan-Raj; Mandeep Hundal; Yiqun Zhang; Marc E Delclos; Christopher H Crane; Prajnan Das; Xin Shelley Wang; Charles S Cleeland; Sunil Krishnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-21       Impact factor: 7.038

Review 8.  The clinical value of erythropoietin in patients with cancer.

Authors:  Ulrich Dührsen
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy.

Authors:  P J Fonseca; E Esteban; P de Vicente; M Luque; B Llorente; M Capelán; J P Berros; G Crespo; A J Lacave
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

10.  Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation.

Authors:  Sara Shoultz-Henley; Adam S Garden; Abdallah S R Mohamed; Tommy Sheu; Michael H Kroll; David I Rosenthal; G Brandon Gunn; Amos J Hayes; Chloe French; Hillary Eichelberger; Jayashree Kalpathy-Cramer; Blaine D Smith; Jack Phan; Zeina Ayoub; Stephen Y Lai; Brian Pham; Merrill Kies; Kathryn A Gold; Erich Sturgis; Clifton D Fuller
Journal:  Int J Cancer       Date:  2015-10-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.